2020 - A Year Full Of Potentials, page-148

Hi TTE

I think you're confusing "investing" in biotech with being a blind fanboy/fangirl of a company.
We're here to make money off potential, the same as you with MSB.
The long-termers here are far in profit, that not even you can doubt that CYP has been the better investment over and beyond MSB.

MSB have definitely paved the road for all other stem cell companies (their success makes other stem cell company's success more likely), but being first means shit all to the people who truly hold power and make the decisions.

I doubt anyone here is arguing that CYP is a sure thing, and neither is MSB, infact far from it.